JP
Insider
John F. Paolini
CHIEF MEDICAL OFFICERJohn F. Paolini (CHIEF MEDICAL OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $3.1M of KNSA (58,424 sh across 2 lots, as filed), executed May 1.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$8.0M
shares × price, as filed
Last traded
May 1
Filed May 5
Median ADV $60.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $9.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
KNSARecent filings
KNSASALE
Kiniksa Pharmaceuticals International, plc
View filing →
$3.1M58,424 sh across 2 lots
Exec May 1
Filed May 5 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $1.8M
40,000 sh across 3 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $3.1M
82,542 sh × $37.14
Exec Oct 31 2025
Filed Nov 4 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $955K
29,325 sh × $32.55
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET